Sanofi is a global biopharmaceutical company headquartered in Paris, France, that develops, manufactures and markets a broad range of prescription medicines, vaccines and consumer healthcare products. Operating under the OTCMKTS symbol SNYNF in the United States, Sanofi’s portfolio spans multiple therapeutic areas including diabetes, oncology, immunology, cardiovascular disease and rare blood disorders. The company also maintains one of the world’s largest vaccine businesses through its Sanofi Pasteur division, supplying immunizations for influenza, meningitis, and other infectious diseases.
Established in 1973 through the merger of several French chemical and pharmaceutical firms, Sanofi has grown through strategic acquisitions and partnerships. Notably, the purchase of Genzyme in 2011 expanded its capabilities in rare diseases, while collaborations with biotechnology companies have strengthened its pipeline in immuno-oncology and monoclonal antibodies. Over the decades, Sanofi has balanced internal research and development with external licensing deals to bolster its position in both established and emerging markets.
The company serves patients in more than 100 countries, with significant operations in Europe, North America, Latin America and Asia-Pacific. Sanofi’s regional hubs oversee manufacturing, regulatory affairs and commercial activities designed to address local healthcare needs. In emerging economies, the company emphasizes access programs and tiered pricing to improve availability of essential medicines and vaccines.
Since 2019, Chief Executive Officer Paul Hudson has led Sanofi’s strategic shift toward innovation and operational efficiency. Under his leadership, the company has pursued a leaner cost structure, refocused R&D investments on high-potential candidates and forged partnerships with leading biotechnology firms. Moving forward, Sanofi aims to strengthen its late-stage pipeline while leveraging digital health initiatives to enhance patient outcomes and drive long-term growth.
AI Generated. May Contain Errors.
Free SNYNF Stock Alerts